Two major pharmaceutical companies developing advanced-stage R&D on Alzheimer’s disease have just pulled the plug on their research. The reason why their approach to Alzheimer’s, Aducanumab, failed is because it didn’t account for a factor that is central
to R&D conducted by biotechnology Company ProMIS Neurosciences Inc.
(TSX:PMN, OTCQB:ARFXF, Forum).
Preclinical studies show the Company's lead antibody candidate, PMN310,
demonstrates a high degree of binding to toxic oligomers from Alzheimer's disease brains without binding to plaque or other non-toxic forms of the toxic oligomer form of
amyloid beta (Aβ).
Not only has an important competitor dropped out of the race to find an Alzheimer’s
treatment, the reason for failure suggests that ProMis is on the right track with its own
research.
Stockhouse is joined by Company President and CEO, Dr. Elliot Goldstein to learn
more about ProMIS’ research and potential to combat Alzheimer’s Disease.
Thematic Insights - The Future of Energy
Stock market close - March 20, 2024
Stock market close - Mar 19, 2024
Stockhouse: March 15 2024 Stock Market Close
Thematic Insights: Why gold is a best-buy for investors in early 2024
Stockhouse Market Close - Mar 13, 2024
Stockhouse Market Close Mar 12, 2024
Thematic Insights: Gold (March 2024)
Stockhouse Market Close- Mar 6, 2024
Stockhouse Market Close Podcast - Feb 29, 2024
SKRR Exploration and F3 Uranium Interview
This Early-Stage Exploration Company is Ready to Dominate the EV Space
How a Canadian-based Helium Company is Meeting Demand in the High-tech Market
A Dual Threat Gold & Silver Opportunity in BC’s Prolific Cariboo Mining Region
Bioasis Technologies: A Very BIG Year in Review
Mining Exploration in the Presence of Giants, in the Heart of the Golden Triangle
The SUPER-State Cannabis Company that’s on the Move
Interview with Mark Selby, CEO of Canada Nickel Co.
Interivew with good natured Products
Iron Ore & Vanadium in Quebec: Who’s Driving BOTH Markets?
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Aligned Money Show
Dubai Property Podcast
IBKR Podcasts
The Ramsey Show
The Clark Howard Podcast